Tag: commercial
Latest article
Lilly’s tirzepatide beats Ozempic in head-to-head kind 2 diabetes trial
Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...
Diabetes screening ought to now begin at 35 for people who find themselves chubby,...
Erica Carbajal - - Wednesday 17th March 2021
Print | E-mail
The U.S. Preventive Services Task Force issued draft recommendations on March 16 to reduce the...
NIH platform will assist information precision diet analysis
June 14, 2021
Watch for 1 minute
Source / information
Disclosure:
Denny and...